Showing results (111-120 of 137) with videos related to

Sort By:
Pageof 14
Plos One|February 27, 2016
Cortical Thickness, Surface Area and Subcortical Volume Differentially Contribute to Cognitive Heterogeneity in Parkinson's DiseaseNiels J H M Gerrits, Anita C van Loenhoud, Stan F van den Berg, et al.
Neuroimage. Clinical|May 15, 2023
Magnetoencephalography to measure the effect of contact point-specific deep brain stimulation in Parkinson's disease: A proof of concept studyLennard I Boon, Wouter V Potters, Arjan Hillebrand, et al.
Brain Pathology (Zurich, Switzerland)|October 13, 2011
The proteome of the locus ceruleus in Parkinson's disease: relevance to pathogenesisKarin D van Dijk, Henk W Berendse, Benjamin Drukarch, et al.
Parkinsonism & Related Disorders|March 6, 2022
Effect of eight-week online cognitive training in Parkinson's disease: A double-blind, randomized, controlled trialTim D van Balkom, Henk W Berendse, Ysbrand D van der Werf, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 25, 2014
The dopamine stabilizer (-)-OSU6162 occupies a subpopulation of striatal dopamine D2/D3 receptors: an [(11)C]raclopride PET study in healthy human subjectsNelleke Tolboom, Henk W Berendse, Josee E Leysen, et al.
Trials|June 24, 2015
BEWARE: Body awareness training in the treatment of wearing-off related anxiety in patients with Parkinson's disease: study protocol for a randomized controlled trialIres Ghielen, Odile A van den Heuvel, Cees J T de Goede, et al.
Brain Topography|February 24, 2004
Localization of slow wave activity in patients with tumor-associated epilepsyJohannes C Baayen, Arent de Jongh, Cornelis J Stam, et al.
Nature Communications|July 18, 2025
Synaptic enrichment of pSer129 alpha-synuclein correlates with dopaminergic denervation in early-stage Parkinson's diseaseIrene Frigerio, Martino L Morella, Amber B Winkelaar, et al.
International Journal of Molecular Sciences|November 17, 2020
CSF Biomarkers Reflecting Protein Pathology and Axonal Degeneration Are Associated with Memory, Attentional, and Executive Functioning in Early-Stage Parkinson's DiseaseLinda P Oosterveld, Tessa I Kuiper, Nour K Majbour, et al.
Journal of Parkinson'S Disease|February 26, 2026
Quantitative measures of total and phosphorylated alpha-synuclein in skin tissue as potential biomarkers for synucleinopathiesBram L van der Gaag, Janna van Wetering, Martino L Morella, et al.
Pageof 14